When Dr Samson Magesa walked away from the busy wards of Mwananyamala Hospital a decade ago, he carried with him the frustrations of a medical professional who had witnessed too many patients ...

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...